News

Metropolis Healthcare Q4 net slips 19% but revenue up 4%; TruHealth shinesThe diagnostics chain's EBITDA margin reduced to 18% over 24.2% in the year-ago quarter. Shares of Metropolis Healthcare Ltd ended at ₹1,702.10, down by ₹11.05, or 0.65%, on the BSE.By Jomy Jos Pullokaran   May 13, 2025, 8:50:11 PM IST (Published)2 Min ReadDiagnostics chain Metropolis Healthcare Ltd on Tuesday, May 13, reported a 19.4% year-on-year (YoY) dip in its Q4 net profit at ₹29 crore, down from ₹36 crore in Q4FY24.

Revenue from operations increased 4.3% to ₹345.3 crore against ₹331 crore last year.

EBITDA fell 22% YoY to ₹62.3 crore in the fourth quarter of this fiscal over ₹80 crore, while the EBITDA margin reduced to 18% over 24.2% in the year-ago quarter.

Also Read: Metropolis Healthcare CEO says Core Diagnostics acquisition may weigh on FY26 margins

In the full year FY25, Metropolis Healthcare reported a 6% YoY growth in patient volume and a 7% increase in test volume. Revenue per patient rose 6% YoY, driven by scientific upselling strategies and benefits from micro-market pricing.

The company’s B2C revenue saw robust growth of 17% for the full year and 14% in Q4FY25, supported by continued investments in improving consumer experience and expanding its service network. On the B2B front, revenue grew 12% YoY in FY25 and 10% in the fourth quarter, aided by improved service quality and stronger partner engagement.

TruHealth, the company’s wellness test portfolio, delivered a 24% growth in revenue in FY25, with Q4 revenue accounting for 19% of total revenues. Speciality diagnostics continued to maintain strong momentum with a 13% YoY growth during the year.

Also Read: Metropolis Healthcare to deepen North India footprint for the next growth phase

Revenue growth from tier-III cities contributed 18% to overall revenue in FY25. The company expanded its footprint to over 750 towns during the year, adding 29 new laboratories and 400 centres, significantly improving last-mile access.

The results came after the close of the market hours. Shares of Metropolis Healthcare Ltd ended at ₹1,702.10, down by ₹11.05, or 0.65%, on the BSE.Continue Reading(Edited by : Shoma Bhattacharjee)Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!TagsearningsMetropolis HealthcareResults Boardroom